Somnology-Jr-Book.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Somnology-Jr-Book.Pdf 1 To Grace Zamudio and Zoe Lee-Chiong. 2 Preface Carpe noctem. Teofilo Lee-Chiong MD Professor of Medicine Division of Sleep Medicine National Jewish Health Denver, Colorado University of Colorado Denver School of Medicine Denver, Colorado Chief Medical Liaison Philips Respironics Murrysville, Pennsylvania 3 Abbreviations AHI Apnea-hypopnea index BPAP Bi-level positive airway pressure CPAP Continuous positive airway pressure CSA Central sleep apnea ECG Electrocardiography EEG Electroencephalography EMG Electromyography EOG Electro-oculography FEV1 Forced expiratory volume in 1 second GABA Gamma-aminobutyric acid N1 NREM stage 1 sleep N2 NREM stage 2 sleep N3 NREM stages 3 (and 4) sleep NREM Non-rapid eye movement O2 Oxygen OSA Obstructive sleep apnea PaCO2 Partial pressure of arterial carbon dioxide PaO2 Partial pressure of arterial oxygen REM Rapid eye movement sleep SaO2 Oxygen saturation SOREMP Sleep onset REM period 4 Table of contents Introduction 15 Neurobiology of sleep 16 Neural systems generating wakefulness 16 Neural systems generating NREM sleep 16 Neural systems generating REM sleep 16 Main neurotransmitters 17 Acetylcholine 17 Adenosine 17 Dopamine 17 Gamma-aminobutyric acid 17 Glutamate 17 Glycine 17 Histamine 18 Hypocretin 18 Melatonin 18 Norepinephrine 18 Serotonin 18 Physiology during sleep 19 Autonomic nervous system 19 Respiratory system 19 Respiratory patterns 19 Cardiovascular system 19 Gastrointestinal system 20 Renal and genito-urinary systems 20 Endocrine system 20 Growth hormone 20 Thyroid stimulating hormone 20 Cortisol 20 Melatonin 21 Testosterone 21 Insulin 21 Leptin 21 Ghrelin 21 Musculoskeletal system 21 Pupillary changes 21 5 Immune system 21 Thermoregulation 21 Metabolic rate 22 Dreaming 22 Regulation of sleep and waking 23 Sleep homeostasis 23 Circadian neurosystem 23 Suprachiasmatic nucleus 24 Melatonin 25 Sleep deprivation 26 Consequences 26 Central nervous system 26 Autonomic nervous system 26 Cognition 26 Respiratory system 26 Endocrine system 26 Metabolism 26 Immune system 26 Behavioral and psychiatric effects 26 Polysomnographic features 27 Insomnia 28 General changes in sleep architecture 28 Prevalence 28 Mechanisms 28 Risk factors 28 Consequences 29 Classification 29 Specific causes 29 Adjustment insomnia 29 Altitude insomnia 30 Behavioral insomnia of childhood 30 Limit-setting sleep disorder 30 Sleep-onset association disorder 30 Fatal familial insomnia 30 Idiopathic insomnia 31 Inadequate sleep hygiene 32 Paradoxical insomnia 32 Psychophysiologic insomnia 32 6 Medications 33 Evaluation of insomnia 33 Polysomnographic features 33 Therapy of insomnia 33 Sleep hygiene 33 Cognitive-behavioral treatments for insomnia 34 Cognitive therapy 34 Paradoxical intention 34 Relaxation techniques 35 Sleep restriction 35 Stimulus control 35 Multi-component behavioral therapy 35 Pharmacotherapy of insomnia 35 Benzodiazepines 37 Benzodiazepine receptor agonists 37 Melatonin receptor agonist 37 Antidepressants and antipsychotics 38 Non-prescription hypnotic agents 38 Melatonin 38 Botanical compounds 38 Excessive sleepiness 39 Prevalence 39 Consequences 39 Mechanisms 39 Specific causes of excessive sleepiness 39 Insufficient sleep syndrome 39 Idiopathic hypersomnia 40 Recurrent hypersomnia 40 Medical, neurological or psychiatric 41 Medications 41 Evaluation of excessive sleepiness 41 Subjective tests of sleepiness 41 Polysomnography 41 Multiple sleep latency test 41 Maintenance of wakefulness test 41 Effective countermeasures for sleepiness 42 Narcolepsy 43 Excessive sleepiness 43 Cataplexy 43 7 Status cataplecticus 43 Sleep hallucinations 44 Sleep paralysis 44 Sleep disturbance 44 Other important clinical features 44 Consequences 44 Prevalence 44 Clinical course 44 Pathophysiology 45 Narcolepsy without cataplexy 45 Secondary narcolepsy 45 Evaluation 46 Polysomnographic features 46 Multiple sleep latency test 46 Maintenance of wakefulness test 46 Cerebrospinal fluid hypocretin-1 46 Human leukocyte antigen typing 47 Therapy 47 Excessive sleepiness 47 Sleep disturbance 47 Cataplexy 47 Obstructive sleep apnea 48 Apnea 48 Hypopnea 48 Respiratory effort-related arousal 48 Complex sleep apnea 48 Apnea-hypopnea index 48 Prevalence 48 Pathophysiology 49 Risk factors 49 Clinical features 49 Physical examination 50 Consequences 50 Evaluation 51 Polysomnographic features 51 Multiple sleep latency test 51 Upper airway imaging studies 52 Therapy 52 8 General measures 52 Positional therapy 52 Oxygen therapy 52 Pharmacologic treatments 52 Positive airway pressure therapy 52 Oral devices 55 Upper airway surgery 56 Residual sleepiness 57 Upper airway resistance syndrome 57 Central sleep apnea 59 Polysomnography 59 Classification 59 Primary central sleep apnea 60 Cheyne Stokes respiration 60 High altitude periodic breathing 60 Medication use 61 Congestive heart failure 61 Sleep-onset central apneas 61 During positive airway pressure titration 61 Therapy of central sleep apnea 61 Hypoventilation syndromes 63 Mechanisms 63 Medical and neurological disorders 63 Idiopathic alveolar hypoventilation 63 Congenital central alveolar hypoventilation 63 Polysomnography 64 Therapy 64 Parasomnias 65 Disorders of arousal 65 Parasomnias occurring during REM sleep 65 Catathrenia 65 Confusional arousals 66 Exploding head syndrome 66 Isolated sleep paralysis 66 Nightmare disorder 67 REM sleep behavior disorder 67 Sleep enuresis 69 9 Sleep-related eating disorder 69 Sleep terrors 70 Sleepwalking 70 Restless legs syndrome and Periodic limb movement disorder 71 Prevalence 71 Classification 71 Risk factors 71 Consequences 72 Evaluation 72 Suggested immobilization test 72 Polysomnography 72 Differential diagnosis 72 Pathophysiology 72 Therapy 73 Dopaminergic agents 73 Benzodiazepines 73 Opioid agents 73 Anticonvulsant agents 73 Periodic limb movements during sleep 73 Periodic limb movement disorder 74 Circadian rhythm sleep disorders 75 Advanced sleep phase syndrome 75 Delayed sleep phase syndrome 75 Free-running circadian rhythm syndrome 76 Irregular sleep-wake rhythm syndrome 77 Jet lag 77 Shift work sleep disorder 78 Medical disorders 79 Asthma 79 Chronic obstructive pulmonary disease 79 Cardiac arrhythmias 80 Chronic pain syndromes 80 Congestive heart failure 80 Coronary artery disease 81 Diaphragm paralysis 81 End-stage renal disease 81 Fibromyalgia 81 10 Gastroesophageal reflux 81 Human immunodeficiency virus infection 82 Hypertension 82 Restrictive pulmonary diseases 83 Sleeping sickness 83 Neurological disorders 84 Alzheimer’s dementia 84 Amyotrophic lateral sclerosis 84 Attention deficit hyperactivity disorder 84 Blindness 84 Cerebral degenerative disorders 84 Down syndrome 85 Headache syndromes 85 Multiple system atrophy 86 Neuromuscular disorders 86 Parkinson disease 86 Seizure disorders 87 Stroke 88 Psychiatric disorders 89 Anxiety disorders 89 Acute stress disorder 89 Generalized anxiety disorder 89 Post-traumatic stress disorder 90 Panic disorder 90 Eating disorders 90 Mood disorders 90 Major depressive episode 90 Manic episode 90 Hypomanic episode 91 Mixed episode 91 Major depressive disorder 91 Bipolar disorder 91 Seasonal affective disorder 91 Atypical depression 92 Schizophrenia 92 Miscellaneous sleep disorders 93 Alcohol-dependent sleep disorder 93 Alternating leg muscle activation 93 11 Benign sleep myoclonus of infancy 93 Environmental sleep disorder 93 Fragmentary myoclonus 94 Hypnagogic foot tremor 94 Hypnotic-dependent sleep disorder 94 Long sleeper 94 Propriospinal myoclonus at sleep onset 95 Rhythmic movement disorder 95 Short sleeper 95 Sleep hyperhidrosis 96 Sleep-related abnormal swallowing 96 Sleep-related bruxism 96 Sleep-related choking syndrome 97 Sleep-related laryngospasm 97 Sleep-related neurogenic tachypnea 97 Sleep-related painful erections 97 Sleep-related leg cramps 98 Sleep start 98 Sleep talking 98 Snoring 98 Stimulant-dependent sleep disorder 99 Sudden infant death syndrome 99 Sudden unexplained nocturnal death 99 Infants and children 100 Milestones in sleep architecture 100 Sleep stages in the first 6 months of age 100 Sleep stages after 6 months of age 101 Milestones in sleep-related behaviors 101 Aggregate hours of sleep per day 101 Insomnia in children 102 Excessive daytime sleepiness 103 Childhood obstructive sleep apnea 104 Apnea of prematurity 104 Infant sleep apnea 105 Apparent life-threatening event 105 Snoring 105 Aging 106 Physiologic changes with aging 106 12 Changes in sleep architecture 106 Insomnia 106 Sleep in women 107 Obstructive sleep apnea 107 Central sleep apnea 107 Menstruation 107 Polycystic ovarian syndrome 108 Pregnancy 108 Postpartum period 108 Menopause 108 Medications and their effects on sleep 110 Alcohol 110 Antidepressants 110 Antipsychotics 111 Drugs of abuse 111 Hypnotic agents 111 Opioids 111 Stimulants 112 Agents that can cause insomnia 112 Agents that can cause sedation 112 Agents causing restless legs syndrome 112 Agents causing REM behavior disorder 112 Polysomnography and other sleep tests 113 Indications 113 Polygraph 113 Derivation 113 Electroencephalography 114 Electroencephalographic waveforms 114 Electro-oculography 115 Chin electromyography 115 Electrocardiography 115 Measuring airflow 116 Measuring respiratory effort 116 Measuring oxygenation and ventilation 116 Identifying snoring 117 Electromyography of the anterior tibialis 117 Scoring sleep stages 117 Adult sleep stages 117 13 Stage wake 117 Stage N1 sleep 118 Stage N2 sleep 119 Stage N3 sleep 120 Stage REM sleep 121 Major body movements 121 Pediatric sleep stage scoring rules 122 Sleep scoring
Recommended publications
  • How to Take a Sleep History
    1/25/2015 How to take a sleep history Joan Santamaria Neurology Service and Multidisciplinary Sleep Disorders Unit Hospital Clínic of Barcelona 1.- Clinical history: Fundamental: the best “sleep test” Examination: helpful, but not always 2.- Investigations : Sleep tests: PSG, Video-PSG, respiratory polygraphy, MSLT, MWT, actimetry 3.- To rush into a sleep test without considering the history is of little use Taking a good sleep history The bed partner is essential By definition, people is unconscious during sleep Parasomnias, PLMs, Snoring, Sleep apnea, Seizures Daytime sleepiness may be neglected by some patients Even in insomnia patients, the bed partner information may be helpful 1 1/25/2015 Three main complaints I cannot sleep as much as I want (insomnia) Excessive daytime sleepiness (hypersomnia) Abnormal behaviors during sleep (parasomnias and other problems…noise, apnea, enuresis, seizures… ) What are the main questions? Nocturnal sleep characteristics Schedule of sleep during the week and week-end or holidays Latency to sleep, number of awakenings and cause (bathroom, pain, nightmare...) Time and type of final awakening (spontaneous/induced) Feel refreshed / tired on awakening? 23 1 4:30 6 8 Nocturnal sleep pattern Sleep onset insomnia 24 1:30 7:30 Delayed sleep phase 24 3 12 Week day Insufficient sleep 24 5:30 1 11 Week end (> 2 hrs additional sleep duration on week ends, high sleep efficiency) 2 1/25/2015 Sleep diary DEFINITION OF INSOMNIA Two key elements Nocturnal sleep: Difficulty in sleeping as much or as deep as one would
    [Show full text]
  • Sleep and Its Disorders: Is the Problem
    38 ISSN 0049-6804. «Врачеб. дело». 2017, № 1–2 ОБЗОР ЛИТЕРАТУРЫ 43. Williams G. R., Duncan Bassett J. H. Local control of thyroid hormone action: role of type 2 deiodinase Deiodinases: the balance of thyroid hormone // J. of Endocrinol. – 2011. – Vol. 209. – P. 261–272. 44. Wittmann G., Harney J. W., Singru P. S. et al. Inflammation-inducible type 2 deiodinase expres- sion in the leptomeninges, choroid plexus, and at brain blood vessels in male rodents // Endocri- nology. – 2014. – Vol. 155. – P. 2009–2019. 45. Yu J., Koenig R. J. Induction of type 1 iodothyronine deiodinase to prevent the nonthyroidal illness syndrome in mice // Endocrinol. – 2006. – Vol. 147, N 7. – Р. 3580–3585. СУЧАСНІ УЯВЛЕННЯ ПРО СИНДРОМ НЕТИРЕОЇДНОЇ ПАТОЛОГІЇ В КЛІНІЧНІЙ ПРАКТИЦІ Н. О. Абрамова, Н. В. Пашковська (Чернівці) Будь-які гострі та хронічні захворювання, що втягують у патологічний процес весь організм, можуть викликати порушення обміну тиреоїдних гормонів на фоні відсутності супутньої патології щитоподібної залози, гіпофіза та (або) гіпоталамуса. Такі порушення називають «син- дромом нетиреоїдної патології» (СНТП), або «синдромом низького Т3», і зустрічаються у 70 % госпіталізованих. У даному огляді ми розглянули етіологію, патогенез та частково шляхи корекції синдрому нетиреоїдної патології. Ключові слова: синдром нетиреоїдної патології, синдром низького Т3, порушення обміну тиреоїдних гормонів. CURRENT VIEWS ON NONTHYROIDAL ILLNESS SYNDROME IN CLINICAL PRACTICE (REVIEW) N. O. Abramova, N. V. Pashkovska (Chernivtsi, Ukraine) Higher State Educational Establishment of Ukraine «Bukovinian State Medical University» Any acute and chronic diseases that involve the whole organism into pathological process, can cause violation of thyroid hormones metabolism against a background of absence of concomitant diseases of thyroid gland, pituitary gland or hypothalamus.
    [Show full text]
  • Autophagy in Trypanosomatids
    Cells 2012, 1, 346-371; doi:10.3390/cells1030346 OPEN ACCESS cells ISSN 2073-4409 www.mdpi.com/journal/cells Review Autophagy in Trypanosomatids Ana Brennand 1,†, Eva Rico 2,†,‡ and Paul A. M. Michels 1,* 1 Research Unit for Tropical Diseases, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, postal box B1.74.01, B-1200 Brussels, Belgium; E-Mail: [email protected] 2 Department of Biochemistry and Molecular Biology, University Campus, University of Alcalá, Alcalá de Henares, Madrid, 28871, Spain; E-Mail: [email protected] † These authors contributed equally to this work. ‡ Present Address: Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, King’s Buildings, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +32-2-7647473; Fax: +32-2-7626853. Received: 28 June 2012; in revised form: 14 July 2012 / Accepted: 16 July 2012 / Published: 27 July 2012 Abstract: Autophagy is a ubiquitous eukaryotic process that also occurs in trypanosomatid parasites, protist organisms belonging to the supergroup Excavata, distinct from the supergroup Opistokontha that includes mammals and fungi. Half of the known yeast and mammalian AuTophaGy (ATG) proteins were detected in trypanosomatids, although with low sequence conservation. Trypanosomatids such as Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. are responsible for serious tropical diseases in humans. The parasites are transmitted by insects and, consequently, have a complicated life cycle during which they undergo dramatic morphological and metabolic transformations to adapt to the different environments.
    [Show full text]
  • Sleepiness the Wheel
    SLEEPINESS AT THE WHEEL WHITE PAPER SLEEPINESS AT THE WHEEL WHITE PAPER Sleepiness at the Wheel WHITE PAPER PREFACE Improving road safety is a priority of the French Government. Among the various causes of road accidents, one of them is especially common on motorways: lack of alertness, which leads to inattention and sleepiness. Lack of alertness is responsible for one in three collisions resulting in deaths on the motorway network, although it is the safest of all road networks! This phenomenon is not fully grasped by the public. Therefore, it is essential to gain knowledge and raise the publics’ awareness as regards sleepiness at the wheel. In more general terms, sleepiness at the wheel remains underestimated both socially and culturally speaking, which is a major issue for road safety and public health. This white book, put together by the French Motorway Companies (ASFA) and the National Institute of Sleep and Vigilance (INSV), presents the most recent knowledge on the subject at both the French and European levels and provides a number of recommendations. By contributing to a better understanding of sleepiness at the wheel, this work will help promote the implementation of new prevention strategies, to further reduce the number of victims on the road. Our objective is to cut down to less than 2000 the number of deaths per year on French roads by 2020. Manuel VALLS French Minister of Interior ASFA and INSV would like to express their deep thanks to the panel of European sleep experts who author this book. Most of them also participate in the research on traffic accidents associated with sleepiness in their own country and thus have contributed to enrich our knowledge and proposals for preventing from the consequences of sleepiness at the wheel.
    [Show full text]
  • COVID-19 Mrna Pfizer- Biontech Vaccine Analysis Print
    COVID-19 mRNA Pfizer- BioNTech Vaccine Analysis Print All UK spontaneous reports received between 9/12/20 and 22/09/21 for mRNA Pfizer/BioNTech vaccine. A report of a suspected ADR to the Yellow Card scheme does not necessarily mean that it was caused by the vaccine, only that the reporter has a suspicion it may have. Underlying or previously undiagnosed illness unrelated to vaccination can also be factors in such reports. The relative number and nature of reports should therefore not be used to compare the safety of the different vaccines. All reports are kept under continual review in order to identify possible new risks. Report Run Date: 24-Sep-2021, Page 1 Case Series Drug Analysis Print Name: COVID-19 mRNA Pfizer- BioNTech vaccine analysis print Report Run Date: 24-Sep-2021 Data Lock Date: 22-Sep-2021 18:30:09 MedDRA Version: MedDRA 24.0 Reaction Name Total Fatal Blood disorders Anaemia deficiencies Anaemia folate deficiency 1 0 Anaemia vitamin B12 deficiency 2 0 Deficiency anaemia 1 0 Iron deficiency anaemia 6 0 Anaemias NEC Anaemia 97 0 Anaemia macrocytic 1 0 Anaemia megaloblastic 1 0 Autoimmune anaemia 2 0 Blood loss anaemia 1 0 Microcytic anaemia 1 0 Anaemias haemolytic NEC Coombs negative haemolytic anaemia 1 0 Haemolytic anaemia 6 0 Anaemias haemolytic immune Autoimmune haemolytic anaemia 9 0 Anaemias haemolytic mechanical factor Microangiopathic haemolytic anaemia 1 0 Bleeding tendencies Haemorrhagic diathesis 1 0 Increased tendency to bruise 35 0 Spontaneous haematoma 2 0 Coagulation factor deficiencies Acquired haemophilia
    [Show full text]
  • Diseases of the Digestive System (KOO-K93)
    CHAPTER XI Diseases of the digestive system (KOO-K93) Diseases of oral cavity, salivary glands and jaws (KOO-K14) lijell Diseases of pulp and periapical tissues 1m Dentofacial anomalies [including malocclusion] Excludes: hemifacial atrophy or hypertrophy (Q67.4) K07 .0 Major anomalies of jaw size Hyperplasia, hypoplasia: • mandibular • maxillary Macrognathism (mandibular)(maxillary) Micrognathism (mandibular)( maxillary) Excludes: acromegaly (E22.0) Robin's syndrome (087.07) K07 .1 Anomalies of jaw-cranial base relationship Asymmetry of jaw Prognathism (mandibular)( maxillary) Retrognathism (mandibular)(maxillary) K07.2 Anomalies of dental arch relationship Cross bite (anterior)(posterior) Dis to-occlusion Mesio-occlusion Midline deviation of dental arch Openbite (anterior )(posterior) Overbite (excessive): • deep • horizontal • vertical Overjet Posterior lingual occlusion of mandibular teeth 289 ICO-N A K07.3 Anomalies of tooth position Crowding Diastema Displacement of tooth or teeth Rotation Spacing, abnormal Transposition Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth K07.4 Malocclusion, unspecified K07.5 Dentofacial functional abnormalities Abnormal jaw closure Malocclusion due to: • abnormal swallowing • mouth breathing • tongue, lip or finger habits K07.6 Temporomandibular joint disorders Costen's complex or syndrome Derangement of temporomandibular joint Snapping jaw Temporomandibular joint-pain-dysfunction syndrome Excludes: current temporomandibular joint: • dislocation (S03.0) • strain (S03.4) K07.8 Other dentofacial anomalies K07.9 Dentofacial anomaly, unspecified 1m Stomatitis and related lesions K12.0 Recurrent oral aphthae Aphthous stomatitis (major)(minor) Bednar's aphthae Periadenitis mucosa necrotica recurrens Recurrent aphthous ulcer Stomatitis herpetiformis 290 DISEASES OF THE DIGESTIVE SYSTEM Diseases of oesophagus, stomach and duodenum (K20-K31) Ill Oesophagitis Abscess of oesophagus Oesophagitis: • NOS • chemical • peptic Use additional external cause code (Chapter XX), if desired, to identify cause.
    [Show full text]
  • Sleep, Its Attributes, Deprivation & Hygiene: a Recapitulation
    Review Article Annals of Sleep Medicine Research Published: 21 Jun, 2019 Sleep, Its Attributes, Deprivation & Hygiene: A Recapitulation Priyanka Malhotra* Nursing in Mental Health Nursing From PGIMER, Chandigarh, India Presently working as Nursing Tutor, AIIMS, Rishikesh, India Abstract Sleep is a biological and behavioral phenomenon that has been studied from many different perspectives. Today it is clear that sleep quantity and quality is related to the development of chronic diseases and even mental disorders. However, many people ignore their sleep habits and fail to take active steps to adopt sleep hygiene practices preferring instead to relay on non-prescribed or prescribed pharmacological products. As a result of the potential consequences of sleep deprivation, health care professionals should be vigilant of how managing underlying medical conditions may help to optimize sleep continuity and consider prescribing interventions that minimize sleep disruption. Keywords: Sleep; Sleep deprivation; Sleep hygiene Introduction Almost every night we are engaging ourselves in a sound sleep. However, pattern of sleep and its features vary from person to person. Various body functions such as metabolism, appetite, cardiovascular system, and immune system has been maintained and regulated by sleep. Hence, for the optimum level of health, sleep is an important factor [1,2]. Sleep is a state of reduced consciousness that is relatively easy to reverse. A normal healthy sleep is distinguish by good quality, appropriate time and regularity, enough duration and without any sleep disorder and disturbance [3]. Attributes of Normal Sleep OPEN ACCESS The stages of sleep have historically been divided into one stage of Rapid Eye Movement (REM) sleep and four stages (Stages 1-4) of Non-Rapid Eye Movement (NREM) sleep that are characterized *Correspondence: by increasing sleep depth.
    [Show full text]
  • Parasomnias Revisited New Mexico Thoracic Society Sapna Bhatia Md 02/25/17 Objectives
    PARASOMNIAS REVISITED NEW MEXICO THORACIC SOCIETY SAPNA BHATIA MD 02/25/17 OBJECTIVES • Appreciate the clinical semiology to help differentiate between REM and NREM parasomnias • Appreciate the ICSD III Classification Scheme for the major parasomnias • Understand management modalities including behavioral and pharmacological for NREM and REM parasomnias • Understand the difference between parasomnias and seizures WHAT ARE PARASOMNIAS? Undesirable motor, or verbal phenomena that arise from sleep or sleep-wake transition PARASOMNIAS: OVERLAPPING STATES REM PARASOMNIAS WAKE NREM PARASOMNIAS REM NREM PARASOMNIAS: DIFFERENTIAL DIAGNOSIS RBD Confusional Arousals Recurrent Isolated Sleep Paralysis Sleepwalking Nightmare Disorder Sleep Terrors WAKE Sleep Related Eating Disorder REM NREM PYSCHOGENIC SEIZURES SPELLS NFLE Dissociative Disorder ICSD II ICSD III REM Parasomnias • RBD • RBD • Recurrent Isolated Sleep • Recurrent Isolated Sleep Paralysis ICSD II VS ICSDParalysis III CLASSIFICATION• Nightmare Disorder • Nightmare Disorder Disorders of arousal • Confusional Arousals • Confusional Arousals (NREM sleep) • Sleepwalking • Sleep Walking • Sleep Terrors • Sleep Terrors • SRED Other Parasomnias • SRED • Sleep Related Dissociative • Sleep Related Dissociative Disorders Disorders • Sleep Enuresis • Sleep Enuresis • Catathrenia SDB • Catathrenia • Exploding Head Syndrome • Exploding Head syndrome • Sleep Related Hallucinations • Sleep Related Hallucinations • Parasomnia, Unspecified • Parasomnia, Unspecified • Parasomnia due to Drug or • Parasomnia
    [Show full text]
  • What Every Clinician Should Know About Polysomnography
    What Every Clinician Should Know About Polysomnography Susheel P Patil MD PhD Introduction Electrical Concepts Current, Voltage, Resistance Capacitance, Inductance, and Impedance Differential Amplifiers Polarity Common Mode Rejection Amplifier Gain, Sensitivity, and Type Patient Ground, Electrical Ground, and Electrical Safety Filters and Filtering Low-Frequency Filters High-Frequency Filters Notch Filters Aspects Unique to Digital Polysomnography Sampling Rate and Aliasing Bit Resolution and Input Voltage Monitor Aliasing Artifacts Updates in Polysomnography Scoring Visual Rules for Sleep Changes in the Scoring of Sleep Under the AASM Manual Comparison of the AASM Manual and R&K Sleep Staging Rules Scoring Reliability of Sleep Staging Under the AASM Manual Scoring of Arousals Movement Rules Scoring of Respiratory Events Summary Polysomnography studies are an essential tool for the sleep physician and aid in the diagnosis and treatment of sleep disorders. Polysomnography refers to the recording, analysis, and interpretation of multiple physiologic signals collected simultaneously. Rapid advancements in technology have transformed the field from a time when analog studies were collected on paper to computer-assisted collection of digitally transformed studies. Sleep clinicians, whether physicians, respiratory thera- pists, or sleep technologists, must therefore have an understanding of a broad array of principles underlying the collection of the various signals. In addition, an understanding of basic technical rules in the evaluation of polysomnography studies is necessary for both the scoring and interpre- tation of such studies. The American Academy of Sleep Medicine published a new manual for the scoring of sleep and associated events in 2007. These changes included modifications to the visual scoring of sleep, the scoring of sleep-disordered breathing events, and movement disorders during sleep.
    [Show full text]
  • Polymorphism Located in TCRA Locus Confers Susceptibility to Essential Hypersomnia with HLA-DRB1&Ast;1501-DQB1&Ast;0602
    Journal of Human Genetics (2010) 55, 63–65 & 2010 The Japan Society of Human Genetics All rights reserved 1434-5161/10 $32.00 www.nature.com/jhg SHORT COMMUNICATION Polymorphism located in TCRA locus confers susceptibility to essential hypersomnia with HLA-DRB1*1501-DQB1*0602 haplotype Taku Miyagawa1, Makoto Honda2,3, Minae Kawashima1,4, Mihoko Shimada1, Susumu Tanaka2, Yutaka Honda3 and Katsushi Tokunaga1 Essential hypersomnia (EHS) exhibits excessive daytime sleepiness without cataplexy and is associated with the HLA-DRB1*1501-DQB1*0602 haplotype, similar to narcolepsy with cataplexy. Single-nucleotide polymorphism (SNP) rs1154155 located in the T-cell receptor a (TCRA) locus has been recently identified as a novel genetic marker of susceptibility for narcolepsy with cataplexy. We investigated whether the SNP was associated with EHS in the Japanese population. We found a significant association with EHS patients possessing the HLA-DRB1*1501-DQB1*0602 haplotype, compared À4 with HLA-matched healthy individuals (Pallele¼0.008; Ppositivity¼5Â10 ), whereas no significant association was observed for EHS patients without this haplotype. Thus, TCRA is a plausible candidate for susceptibility to EHS patients positive for the HLA-DRB1*1501-DQB1*0602 haplotype. Journal of Human Genetics (2010) 55, 63–65; doi:10.1038/jhg.2009.118; published online 20 November 2009 Keywords: essential hypersomnia; HLA; narcolepsy; TCRA INTRODUCTION possible association between SNP rs1154155 in the TCRA locus and Earlier studies have revealed that narcolepsy with cataplexy is asso- essential hypersomnia (EHS), CNS hypersomnia similar to narcolepsy ciated with the human leukocyte antigen (HLA) and T-cell receptor a with cataplexy, with regard to the symptom of excessive daytime (TCRA) genes.
    [Show full text]
  • The Battle Is Not Over Until It Is Won
    HUMAN AFRICAN TRYPANOSOMIASIS SLEEPING SICKNESS The battle is not over until it is won Sleeping sickness, or human African trypa- melarsoprol. The latter, however, is still the nosomiasis, threatens millions of people in first-line treatment for the less commonT.b. 36 countries across sub-Saharan Africa. The rhodesiense HAT. Democratic Republic of the Congo bears the To contribute to the WHO elimination goal, a brunt, accounting for 83% of all cases. In the ‘test and treat’ strategy that would be imple- 1960s there were less than 5,000 patients mented at the primary healthcare level is on suffering from the disease in the whole of the the horizon, with potential simple oral pills continent. However, the end of the 20th cen- for both the early and late stage as well as tury – with internal conflict, competing health both types of HAT, that are currently in devel- priorities, and decolonization – witnessed a opment, along with new rapid diagnostics, halt in the successful control methods, and which together would remove the need for the number of cases reported rose painful and dangerous lumbar punc- steeply, peaking in 1998 with tures. This would mean that rural over 37,000 cases reported in health centres, rather than hos- that year. Nowadays, thanks pitals, will play an increasingly to the combined efforts of important role, especially as the WHO, National Sleeping number of reported cases con- Sickness Control Pro- tinues to dwindle. grammes, NGOs and other partners, the disease has once more been brought under control, and since 2010 the number of reported cases has fallen below 8,000.
    [Show full text]
  • Diagnostic Testing for Sleep Disorders
    Diagnostic Testing for Sleep Disorders LISA CUTCHEN MD ASSISTANT PROFESSOR UNIVERSITY OF NEW MEXICO HOSPITALS SLEEP DISORDERS CENTER NOVEMBER 11, 2016 Objectives of Talk • Describe the most common types of sleep tests • Explain how and why we test for sleep disorders • Briefly review the most common sleep disorders that require testing Diagnostic Tests for Sleep Disorders • Polysomnography (PSG, Sleep Study) • Overnight Oximetry • Actigraphy • Multiple Sleep Latency Test (MSLT) • Maintenance of Wakefulness Test (MWT)f Diagnostic Tests for Sleep Disorders Sleep Test Quality Measured Polysomnography Simultaneous recording of multiple biophysiological signals to study and characterize sleep and sleep disorders. Overnight oximetry Monitor oxygen saturation and heart rate in bed overnight. Actigraphy Measure sleep/wake patterns over long periods of time by monitoring body movements. Multiple Sleep Latency Test Test ability to fall asleep during the day when permitted and whether REM sleep appears earlier than usual. Maintenance of Wakefulness Test Test ability to stay awake with low levels of stimulation without resorting to extraordinary measures. Polysomnography • 4 Levels of Polysomnograms • Conducted during the patient’s Level I Full PSG, in-lab, attended typical sleep time Level II Full PSG, unattended • Varying levels of complexity Partial PSG, ≥4 • # of signals recorded cardiorespiratory Level III simultaneously parameters, unattended, • Whether attended by a sleep typically done at home technologist Partial PSG, 1-2 cardiorespiratory
    [Show full text]